TCR affinity and negative regulation limit autoimmunity-Reference-Cited by-同舟云学术

TCR affinity and negative regulation limit autoimmunity

Published:2004-10-03 Issue:11 Volume:10 Page:1234-1239
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Gronski Matthew A,Boulter Jonathan M,Moskophidis Demetrius,Nguyen Linh T,Holmberg Kaisa,Elford Alisha R,Deenick Elissa K,Kim Hee O,Penninger Josef M,Odermatt Bernhard,Gallimore Awen,Gascoigne Nicholas R J,Ohashi Pamela S

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://www.nature.com/articles/nm1114.pdf

Reference35 articles.

1. Oldstone, M.B.A. Molecular mimicry and immune-mediated diseases. FASEB J. 12, 1255–1265 (1998).

2. Wucherpfennig, K.W. Structural basis of molecular mimicry. J. Autoimmun. 16, 293–302 (2001).

3. Benoist, C. & Mathis, D. Autoimmunity provoked by infection: how good is the case for T cell epitope mimicry? Nat. Immunol. 2, 797–801 (2001).

4. Bachmaier, K. et al. Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b. Nature 403, 211–216 (2000).

5. Chiang, Y.J. et al. Cbl-b regulates the CD28 dependence of T-cell activation. Nature 403, 216–220 (2000).

Cited by 125 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Burden and disease pathogenesis of influenza and other respiratory viruses in diabetic patients;Journal of Infection and Public Health;2022-04

2. Cancer and immunity;Cancer;2022

3. Immune Checkpoints and Innate Lymphoid Cells—New Avenues for Cancer Immunotherapy;Cancers;2021-11-27

4. Ubiquitination in T-Cell Activation and Checkpoint Inhibition: New Avenues for Targeted Cancer Immunotherapy;International Journal of Molecular Sciences;2021-10-06

5. Enhanced antitumor immunity by a novel small molecule HPK1 inhibitor;Journal for ImmunoTherapy of Cancer;2021-01